Outset Medical, Inc.
OM
$11.58
$0.726.63%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 29.47M | 28.67M | 27.39M | 28.17M | 30.51M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 29.47M | 28.67M | 27.39M | 28.17M | 30.51M |
| Cost of Revenue | 18.14M | 18.85M | 17.61M | 19.95M | 22.67M |
| Gross Profit | 11.33M | 9.82M | 9.78M | 8.22M | 7.84M |
| SG&A Expenses | 21.85M | 25.52M | 30.81M | 32.49M | 30.87M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 45.77M | 52.51M | 58.15M | 65.08M | 65.33M |
| Operating Income | -16.31M | -23.84M | -30.76M | -36.91M | -34.82M |
| Income Before Tax | -25.64M | -27.76M | -34.30M | -39.78M | -38.49M |
| Income Tax Expenses | -4.00K | 182.00K | 151.00K | 162.00K | 112.00K |
| Earnings from Continuing Operations | -25.64M | -27.94M | -34.45M | -39.94M | -38.60M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.64M | -27.94M | -34.45M | -39.94M | -38.60M |
| EBIT | -16.31M | -23.84M | -30.76M | -36.91M | -34.82M |
| EBITDA | -14.90M | -22.45M | -29.29M | -35.45M | -33.38M |
| EPS Basic | -7.29 | -8.30 | -9.96 | -11.77 | -11.52 |
| Normalized Basic EPS | -3.57 | -5.15 | -6.20 | -7.33 | -6.71 |
| EPS Diluted | -7.29 | -8.30 | -9.96 | -11.77 | -11.52 |
| Normalized Diluted EPS | -3.57 | -5.15 | -6.20 | -7.33 | -6.71 |
| Average Basic Shares Outstanding | 3.52M | 3.37M | 3.46M | 3.39M | 3.35M |
| Average Diluted Shares Outstanding | 3.52M | 3.37M | 3.46M | 3.39M | 3.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |